Obstructive sleep apnea and type 2 diabetes

Area of Science:

• Endocrinology
• Sleep Medicine
• Metabolic Disorders

Background:

• Type 2 diabetes and obstructive sleep apnea (OSA) are prevalent conditions with significant public health implications.
• Evidence suggests a link between snoring/OSA and altered glucose metabolism, positioning OSA as a potential risk factor for type 2 diabetes.
• OSA's features, like intermittent hypoxia and sleep fragmentation, may contribute to diabetes development and treatment resistance.

Purpose of the Study:

• To review the complex relationship between obstructive sleep apnea (OSA) and type 2 diabetes.
• To explore potential pathophysiological mechanisms linking the two conditions.
• To inform clinicians about the bidirectional associations from both sleep and diabetes perspectives.

Main Methods:

• Literature review of current scientific data.
• Analysis of pathophysiological considerations.
• Synthesis of evidence on the interplay between OSA and type 2 diabetes.

Main Results:

• OSA is associated with glucose metabolism alterations and may be a risk factor for type 2 diabetes.
• Continuous positive airway pressure (CPAP) therapy for OSA may improve metabolic abnormalities, contingent on compliance.
• Type 2 diabetes may also contribute to sleep apnea, particularly in patients with autonomic neuropathy.

Conclusions:

• Clinicians must recognize the bidirectional relationship between OSA and type 2 diabetes.
• Understanding these connections is crucial for effective patient management from both sleep and diabetes viewpoints.
• Further research into the intricate links between these conditions is warranted.